Webinars

EpiVax takes great pride in providing industry leading and thought provoking content.

Here you may find information on upcoming webinars such as registration and speaker info as well as links to pre-recorded webinars that have passed.

Please reach out to info@epivax.com should you encounter issues with any link.

  • EpiVax at USP June 3-4

    Posted on June 3, 2013 by Anthony Marcello
    Measurement of Residual Host Cell Protein and DNA in Biotechnology Products Work Shop On Monday, June 3rd at 2:35 PM EpiVax’s CEO/CSO Dr. Annie De Groot presented a talk on the Immunogenicity Analysis of CHOP Contaminants in Therapeutic Protein Formulations. The workshop was hosted by USP and BEBPA, and designed specifically for the biopharmaceutical industry. The meeting ...
    Read more
  • EpiVax Immunogenicity Seminar – Westin Tokyo 2013

    Posted on May 15, 2013 by Anthony Marcello
    EpiVax was in Japan from May 8th – 15th hosting our semiannual immunogenicity seminar. The ‘Westin Immunogenicity Seminar’ was a great success. Thank you to all the wonderful speakers and attendees that made our seminar possible. We are looking forward to our following visit in the Fall, probably in late October, for our next meeting. We will keep you all up-to-date on our ...
    Read more
  • Annie De Groot on Pandemic Influenza Vaccines at the 11th Annual EID and Biodefense meeting.

    Posted on May 11, 2013 by Anthony Marcello
    EpiVax will be at the 11th Annual EID and Biodefense Meeting, June 17-19, 2013 at the Almas Temple Club, Washington, DC. Dr. Annie De Groot will be joining a panel of vaccine and influenza experts to discuss pandemic universal influenza vaccines. See EID and Biodefense Agenda Here Panel: Towards Universal Pandemic Influenza Vaccines Influenza has officially moved into epidemic status for 2013. Work towards ...
    Read more
  • 7th Vaccine & ISV Congress, ICoVax 2013 & EpiVax Cocktail Reception in Spain!

    Posted on May 7, 2013 by Anthony Marcello
    EpiVax will be in Sitges, Spain October 26th – 29th. We will be attending the 7th Vaccine & ISV Congress where we will be sponsoring an ‘EpiVax Welcome Cocktail Reception‘ on Sunday the 27th. Come join us for a time to connect, network and enjoy a cocktail in beautiful Sitges, Spain. We will also be attending the ...
    Read more
  • Immunopathology of T1D & Advances in the Knowledge and Treatment of Autoimmunity – Whistler BC – April 4-9

    Posted on March 26, 2013 by Anthony Marcello
    Immunopathology of T1D & Advances in the Knowledge and Treatment of Autoimmunity – Whistler BC – April 4-9 EpiVax’s Dr. Leslie Cousens will be attending Keystone’s Immunogpathology of T1D conference this April. She will be presenting a poster depicting some fascinating data relating to T1D and Tregitopes! Check out the links below: EpiVax_T1D_Keystone_Conference_Poster_25Mar13 Poster Number: 1011 Poster Title: Application of Tregitopes for tolerance induction ...
    Read more
  • Fourth Immunoinformatics and Computational Immunology Workshop (ICIW 2013)

    Posted on March 22, 2013 by Anthony Marcello
    Fourth Immunoinformatics and Computational Immunology Workshop (ICIW 2013) September 22, 2013 DoubleTree by Hilton Hotel Bethesda – Washington DC, USA, in conjunction with ACM-BCB, September 22-25, 2013 EpiVax will be making a stop in DC this September at the ICIW Workshop 2013! EpiVax’s propriety in-silico platforms embody the essence of  “Bridging Immunology and Computer Science” by enabling drug developers to design more effective vaccines and safer biologics. We hope to see you ...
    Read more
  • Immunogenicity Seminar 2013 – Tokyo, Japan

    Posted on March 19, 2013 by epivax3
    Dr. Annie De Groot will be in Japan from May 8th – 15th, to meet with collaborators and host a semi-annual seminar on immunogenicity. Please see below for details. Sign Up Here! (フォームを登録) –  PDF Agenda (議題) Immunogenicity Seminar 2013 Sponsored by: The Institute for Immunology and Informatics (iCubed), University of Rhode Island & EpiVax, Inc. Venue: The Westin Tokyo – Kiri Room Thursday, May ...
    Read more
  • Hawaii-tope at AAI!

    Posted on March 12, 2013 by Anthony Marcello
    SAVE THE DATE! EpiVax is hosting a cocktail reception at University of Hawaii’s new Cancer Center (at the Sullivan Center), Sunday May 5th, 5:30 – 8:30 pm! Hawaii-tope will be a cocktail and appetizer reception sponsored by EpiVax and the venue was generously donated by Dr. Michele Carbone, Director of UHCC. If you are attending the AAI conference or will be in the area, please come and ...
    Read more
  • Tregitope West Seminar at AAPS!

    Posted on March 11, 2013 by Anthony Marcello
    Tregtiope West was a great success! We would like to say ‘thank you’ to all of our speakers and to all those who attended. We had a wonderful turnout and your participation is very much appreciated. See below for a digital copy of the handouts and links to our posters. Click Here For Full Agenda Full Tregitope West Printout ...
    Read more
  • Biowarfare Experts Speak in Providence

    Posted on October 15, 2012 by Annie De Groot
    Bioterror is the real threat. At the most recent joint US-Korea wargames, held on the border of North and South Korea, biowarfare was one of the threats introduced, to which allied forces had little to no defense. That exercise drove home the importance of biowarfare preparedness, and the military is currently scrambling to get up ...
    Read more
  • Summiting on Immunogenicity and Epitope Networks

    Posted on October 11, 2012 by Annie De Groot
    EpiVax is attending the Immunogenicity Summit in Bethesda this week. Look for Leslie and Annie in person (Annie is usually at the microphone asking questions about HLA associations). We will be piloting some new slides on Epitope Networks. (For more on that, see the link to our CHO/Host Cell protein talk, which is also available ...
    Read more
  • Hands On Vaccine Design in Yokohama

    Posted on October 3, 2012 by Annie De Groot
    Modern Genome-Based Vaccine Design Sponsored by: EpiVax & iCubed Venue: Pacifico Yokohama: 1-1-1, Minato Mirai, Nishi-ku, Yokohama, Japan  Friday November 16th, 9:00 am – 5:00 pm Speakers: Dr. Hiroshi Kiyono M.D. Professor and Dean, Institute of Medical Science, University of Tokyo Dr. Annie De Groot M.D. Professor and Director, Institute of Immunology and Informatics, University of Rhode Island CEO/CSO, EpiVax  Dr. Takuya Tsunoda, M.D., Ph.D. President & CEO OncoTherapy Science, ...
    Read more
  • Tregitope World Tour Fall 2012

    Posted on October 2, 2012 by Anthony Marcello
    Our Tregitope tour continues this month and on through the fall including stops in Orlando, Bethesda and Yokohama. Take a look at the list below and let us know if you’d like us to visit you while we’re in the area. ICIW 2012 Tutorial Session 10/7 – 10/10 In conjunction with: ACM International Conference on Bioinformatics and Computational ...
    Read more
  • EpiVax to attend ICIW 2012

    Posted on July 26, 2012 by Anthony Marcello
    The Third Immunoinformatics and Computational Immunology Workshop will be held in conjunction with the ACM International Conference on Bioinformatics and Computational Biology in Orlando, FL on October 7-10 2012. The main theme of this meeting is “Bridging Immunology and Computer Science“. Nowadays computational methods are integral to virtually every research and development project in every discipline. ...
    Read more
  • Tregitope Wins Big SBIR Program

    Posted on April 9, 2012 by Annie De Groot
    Providence-based biotech EpiVax, Inc. was awarded a new NIH SBIR Phase II grant totaling $1.5M in funding from the National Institutes of Health’s (NIH) NIDDK to explore formulation, dose, route and delivery vehicle for Tregitope through the NIH Small Business Innovation Research (SBIR) program. EpiVax anticipates receiving an additional SBIR award of approximately $775,000 within ...
    Read more
  • Srini Kaveri to discuss IVIG and Tregitope MOA at 4th Tregitope Update

    Posted on April 2, 2012 by Annie De Groot
    The 4th Annual Tregitope update will be held in Baltimore Maryland on April 20th, 2012 (Click here for more information). Dr. Srini Kaveri of the Centre de Recherche des Cordeliers (INSERM) in Paris will provide an update on the mechanism of action of IVIG with an eye to parallels with Tregitope. A wide range ...
    Read more
  • Save the Date – 6th Vaccine Renaissance, Providence Rhode Island

    Posted on March 31, 2012 by Annie De Groot
    EpiVax is a proud sponsor of the 6th Annual Vaccine Renaissance Conference scheduled for October 15-17, 2012 in Providence, Rhode Island.
    Read more
  • Updated list of Immunogenicity and Tregitope Talks 2012

    Posted on March 20, 2012 by Annie De Groot
    Where will we be in Spring 2012? Click here to hear about our latest research and cutting edge approaches to immunogenicity solutions. . .
    Read more
  • Westin Immunogenicity Seminar March 16th

    Posted on March 4, 2012 by Annie De Groot
    The Westin Seminar is back! Join us in Tokyo on March 16th to discuss immunogenicity risk and mitigation.
    Read more
  • Spring 2012 Immunogenicity Workshop Schedule

    Posted on February 3, 2012 by Anthony Marcello
    Come participate in one of the following hands-on demonstrations of our bioinformatics tools!  Each of these workshops features presentations and demonstrations led by our expert immunoinformaticians. Learn from the best! Hands-on Workshops! 5th Antibody Generation, Engineering & Design Conference Frankfurt, Germany Le Meridien Parkhotel, Frankfurt, Germany 29th of February 2012 Half-Day Workshop February 29th: Latest Advances in Reducing the Risk of ...
    Read more
  • Happy New Year! Tregitope World Tour 2012

    Posted on January 1, 2012 by Annie De Groot
    It’s a New Year (2012) and our resolution is to keep you better informed. Here’s a list of our upcoming conferences. . . .
    Read more
  • Westin Immunogenicity Seminar September 27 2011, Tokyo, Japan

    Posted on September 5, 2011 by Annie De Groot
    Westin Immunogenicity Seminar 2011 Tuesday, September 27, 2011 9:45 am – 6:10 pm Kiri Room The Westin Tokyo 1-4-1 Mita Meguro-ku, Tokyo 153-8580 Japan Speakers: Annie De Groot M.D. Director and Professor, Institute of Immunology and Informatics,University of Rhode Island and CEO/CSO EpiVax; Frances Terry, Immunoinformatics / Bioinformatics Specialist, EpiVax, Inc. Keizo Yoshida Ph.D., EpiVax Asia   9: 00 – 9 :45  AM Registration / Breakfast 9: ...
    Read more
  • Tregitope World Tour 2011

    Posted on August 16, 2011 by Annie De Groot
    Tregitope offers an opportunity to rethink protein therapeutics, immunogenicity and tolerance. Evidence is accumulating that Tregitopes are the ‘natural off switch’, leading to suppression of inflammatory T cell responses, and modulating the phenotype of antigen presenting cells. Learn more about Tregitope by participating in the following conferences where the collective work of the Tregitope researchers ...
    Read more
  • Immunogenicity and Vaccine Talks 2011

    Posted on March 26, 2011 by Annie De Groot
    Come hear the latest updates on better proteins and vaccines by design – See our list of speaking engagements and appearances here:
    Read more
  • Immunogenicity: Determinants and Correlates

    Posted on March 5, 2011 by Annie De Groot
    A ‘don’t-miss’ meeting of academic researchers, immunologists, and industry scientists gathering to discuss in silico, in vitro and in vivo drivers of human immune response. The meeting is followed by a hands-on training in immunoinformatics (TRIAD Toolkit) and the annual Tregitope meeting (discussion of tolerance-inducing Tregitope).
    Read more
  • Agenda for Immunogenicity Determinants and Correlates Conference

    Posted on March 5, 2011 by Annie De Groot
    Agenda for Immunogenicity Determinants and Correlates Conference – Valid as of March 05, 2011
    Read more
  • 4th Tregitope Update – Open Meeting May 11 2011

    Posted on February 13, 2011 by Annie De Groot
    Tregitopes are small peptidic regulatory T-cell epitopes derived from human immunoglobulins that activate regulatory T cells (Tregs). Tregitope therapy has broad-reaching implications, offering new treatments for autoimmune diseases (e.g. type 1 juvenile diabetes, multiple sclerosis, rheumatoid arthritis, and lupus), allergies, and transplantation rejection. In previous meetings, the members of the Tregitope Collaborators team have demonstrated ...
    Read more
  • Immunogenicity Determinants and Correlates: Registration Now Open

    Posted on February 13, 2011 by Annie De Groot
    Immunogenicity: Determinants and Correlates is a non-commercial meeting, sponsored by the Institute for Immunology and Informatics and organized by individuals from a wide range of backgrounds including industry and academic settings. The current agenda, confirmed speakers, and the registration website are now posted for your review.
    Read more
  • Immunogenicity Seminar @ Westin Tokyo 2011

    Posted on February 5, 2011 by Annie De Groot
    Expert immunologist and Biotech CEO Dr. Annie De Groot of EpiVax, Inc. who is also faculty member of the Brown University Medical School and Professor at the University of Rhode Island, will provide a detailed discussion of immunogenicity and tolerance for a highly selected audience. We will address the following important questions: (1) What drives the ...
    Read more
  • Immunogenicity: Determinants and Correlates

    Posted on January 25, 2011 by Annie De Groot
    SAVE THE DATE May 9, 10 and 11 1st Immunogenicity – Determinates and Correlates Providence, RI
    Read more
  • Immunogenicity, Tregitopes and Tolerance 2011

    Posted on December 21, 2010 by Annie De Groot
    Annie De Groot, EpiVax CEO will be speaking at the following conferences. Please click on the links for more information. We look forward to meeting you there! Invited Speaker. Regulating Immune Response in Biologics – A Paradigm- Shifting Solution. Session: Immunogenicity Issues. 2nd Annual Advancing Biologics from the Lab to the Clinic, Amsterdam, Netherlands. January 25-26, ...
    Read more